285
Views
9
CrossRef citations to date
0
Altmetric
Drug Profile

Cost–effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections

&
Pages 683-698 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (8)

Claire Roger, Jason A. Roberts & Laurent Muller. (2017) Clinical Pharmacokinetics and Pharmacodynamics of Oxazolidinones. Clinical Pharmacokinetics 57:5, pages 559-575.
Crossref
Cecilia Martín-Gandul, M. J. Mayorga-Buiza, E. Castillo-Ojeda, M. J. Gómez-Gómez, M. Rivero-Garvía, M. V. Gil-Navarro, F. J. Márquez-Rivas & M. E. Jiménez-Mejías. (2016) Sequential antimicrobial treatment with linezolid for neurosurgical infections: efficacy, safety and cost study. Acta Neurochirurgica 158:10, pages 1837-1843.
Crossref
Nuggehally R. Srinivas & Muzeeb Syed. (2016) Applicability of a Single Time Point Strategy for the Prediction of Area Under the Concentration Curve of Linezolid in Patients: Superiority of C trough- over C max-Derived Linear Regression Models. Drugs in R&D 16:1, pages 69-79.
Crossref
Konstantinos Z Vardakas & Matthew E Falagas. (2014) Dalbavancin: re-enforcing the arsenal against Gram-positive bacteria causing skin and skin structure infections. Clinical Investigation 4:1, pages 63-75.
Crossref
Sangeetha Thirumazhisi Sachithanandam. (2014) Rising Methicillin-Resistant Staphylococcus aureus Infections in Ear, Nose, and Throat Diseases . Case Reports in Otolaryngology 2014, pages 1-3.
Crossref
Ewa Szczypinska, Alexander Velazquez, Diana Salazar, C Andrew DeRyke, Beata Raczynski & Mark R Wallace. (2013) The impact of initial antibiotic therapy (linezolid, vancomycin, daptomycin) on hospital length of stay for complicated skin and soft tissue infections. SpringerPlus 2:1.
Crossref
S. J. van Hal & V. G. Fowler. (2013) Reply to Parra-Ruiz. Clinical Infectious Diseases 57:8, pages 1219-1220.
Crossref
J. Parra-Ruiz. (2013) Treating Patients With the Best Drugs. Clinical Infectious Diseases 57:8, pages 1218-1219.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.